Which medication category is used to prevent clot formation by inhibiting platelet aggregation?

• A. Angiotensin converting enzyme
• B. Anticoagulants
• C. Platelet aggregation inhibitors
• D. Diuretics

Answer: (C)

Focusing on preventing clot formation by stopping platelets from clumping together targets how arterial clots usually start. Platelet aggregation inhibitors work by interfering with platelet activation and aggregation, so they prevent the formation of the initial platelet plug that can lead to a clot. This category includes drugs like aspirin and other agents that block platelet receptors or signaling pathways, all aimed at keeping platelets from sticking to each other.

In contrast, other options target different parts of clot formation. Anticoagulants slow the coagulation cascade to prevent fibrin clot formation, which is a different mechanism and is often used for venous thrombosis or atrial thrombi. The remaining choices don’t primarily affect platelets or clot formation in the same way, and diuretics/ACE inhibitors serve unrelated indications.

So, the category that best fits “prevent clot formation by inhibiting platelet aggregation” is the platelet aggregation inhibitors.